Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Pieters

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Experimental Hematology|July 1, 2015
Novel biological insights in T-cell acute lymphoblastic leukemiaKaat Durinck, Steven Goossens, Sofie Peirs, et al.
Oncogene|November 21, 2023
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoidsHélène Lasolle, Andrea Schiavo, Adrien Tourneur, et al.
Science Advances|March 27, 2021
Cell-penetrating Alphabody protein scaffolds for intracellular drug targetingErwin Pannecoucke, Maaike Van Trimpont, Johan Desmet, et al.
Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.
Blood|September 30, 2016
The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signalingJin Li, Tamara Riedt, Steven Goossens, et al.
Blood|October 17, 2014
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemiaJoni Van der Meulen, Viraj Sanghvi, Konstantinos Mavrakis, et al.
Genes, Chromosomes & Cancer|February 21, 2021
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemiaValentina Bardelli, Silvia Arniani, Valentina Pierini, et al.
Blood|September 24, 2024
Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemiaQi Jin, Ethan Harris, Jacquelyn A Myers, et al.
The Journal of Experimental Medicine|August 18, 2021
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in miceTim Pieters, Sara T'Sas, Stijn Vanhee, et al.
Hemasphere|March 11, 2024
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Experimental Hematology|July 1, 2015
Novel biological insights in T-cell acute lymphoblastic leukemiaKaat Durinck, Steven Goossens, Sofie Peirs, et al.
Oncogene|November 21, 2023
Dual targeting of MAPK and PI3K pathways unlocks redifferentiation of Braf-mutated thyroid cancer organoidsHélène Lasolle, Andrea Schiavo, Adrien Tourneur, et al.
Science Advances|March 27, 2021
Cell-penetrating Alphabody protein scaffolds for intracellular drug targetingErwin Pannecoucke, Maaike Van Trimpont, Johan Desmet, et al.
Science Advances|November 1, 2024
A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemiaLisa Demoen, Filip Matthijssens, Lindy Reunes, et al.
Blood|September 30, 2016
The EMT transcription factor Zeb2 controls adult murine hematopoietic differentiation by regulating cytokine signalingJin Li, Tamara Riedt, Steven Goossens, et al.
Blood|October 17, 2014
The H3K27me3 demethylase UTX is a gender-specific tumor suppressor in T-cell acute lymphoblastic leukemiaJoni Van der Meulen, Viraj Sanghvi, Konstantinos Mavrakis, et al.
Genes, Chromosomes & Cancer|February 21, 2021
MYB rearrangements and over-expression in T-cell acute lymphoblastic leukemiaValentina Bardelli, Silvia Arniani, Valentina Pierini, et al.
Blood|September 24, 2024
Disruption of cotranscriptional splicing suggests RBM39 is a therapeutic target in acute lymphoblastic leukemiaQi Jin, Ethan Harris, Jacquelyn A Myers, et al.
The Journal of Experimental Medicine|August 18, 2021
Cyclin D2 overexpression drives B1a-derived MCL-like lymphoma in miceTim Pieters, Sara T'Sas, Stijn Vanhee, et al.
Hemasphere|March 11, 2024
<i>Myb</i> overexpression synergizes with the loss of <i>Pten</i> and is a dependency factor and therapeutic target in T-cell lymphoblastic leukemiaAndré Almeida, Sara T'Sas, Luca Pagliaro, et al.
Pageof 4